Carvedilol Phosphate

CAS 374779-45-0 6 current records 4 historicalSmall Molecule

Who holds supplier records for Carvedilol Phosphate? 6 organisations hold a current record for Carvedilol Phosphate: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2), Spain (1), Netherlands (1), Poland (1) and 1 other country (1).

Most records are filed under another form of this substance: Carvedilol (23 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Carvedilol Phosphate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/carvedilol-phosphate

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Carvedilol Phosphate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Carvedilol Phosphate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (4)

Organisations whose Type II DMFs for Carvedilol Phosphate are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Carvedilol Phosphate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201167).

Chemical identity

IUPAC name
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol;phosphoric acid
Canonical SMILES
COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O.OP(=O)(O)O
InChIKey
XCPXNPBILMXKNX-UHFFFAOYSA-N
Synonyms
Carvedilol phosphate, Carvedilol phosphate hemihydrate, Carvedilol phosphate hydrate, Coreg cr, SK&F-105517-D, SKF 105517D, SKF-105517D, Carvedilol phosphate anhydrous, RefChem:200086, Carloc, NSC751177, Q27251720

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
alpha-Adrenergic Blocker; beta-Adrenergic Blocker
Mechanism of action
Adrenergic alpha-Antagonists; Adrenergic beta1-Antagonists; Adrenergic beta2-Antagonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Carvedilol Phosphate?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Carvedilol Phosphate: Macleods Pharmaceuticals Ltd. (India), MATRIX PHARMACORP PRIVATE LTD (India), MOEHS IBERICA SL (Spain), TAPI NL BV (Netherlands), Zakłady Farmaceutyczne Polpharma S.A. (Poland) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Carvedilol Phosphate Drug Master Files are active?

Macleods Pharmaceuticals Ltd. (DMF 30566), MATRIX PHARMACORP PRIVATE LTD (DMF 20401), MOEHS IBERICA SL (DMF 44804), TAPI NL BV (DMF 23312), Zakłady Farmaceutyczne Polpharma S.A. (DMF 20633) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 25721). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Carvedilol Phosphate records mean?

4 organisations have only inactive Type II DMFs for Carvedilol Phosphate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Carvedilol Phosphate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Carvedilol Phosphate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.